News
Nuvation Bio: A Potentially Transformative Acquisition (NYSE:NUVB)
Today, we put Nuvation Bio (NYSE:NUVB) in the spotlight for the first time. The stock price of this oncology focused…
Atlassian: Collaboration Kings With A Cloudy Future (NASDAQ:TEAM)
Investment Thesis Atlassian (NASDAQ:TEAM) is richly valued for what it offers investors. This business was once flying high and could…
Autodesk Stock: Buy On Accelerating Growth & Improved Certainty (Rating Upgrade) (ADSK)
In my last article on Autodesk (NASDAQ:ADSK) from September 2023, I gave the stock a Hold rating, driven primarily by…
Estimate $450 Value Per Class B Share As Book Value Eclipses $600 Billion (NYSE:BRK.B)
At current market levels, I expect Berkshire Hathaway's (NYSE:BRK.B) book value to exceed $600 billion this quarter - dwarfing the…
Tilly’s Valuation Keeps Decreasing; Not An Opportunity Without Turnaround Signs (TLYS)
This article covers Tilly's (NYSE:TLYS) 1Q24 results and earnings call. Tilly's is an apparel retailer from the US. I started…
JBBB ETF: Balancing Risk Versus Reward (BATS:JBBB)
While the stock market is making new highs and those of us who are recently retired or are soon to…
Herc Holdings Stock: Patience Should Yield Strong Results (NYSE:HRI)
Some investment opportunities generate significant upside for investors in a short window of time. Others, however, require patience. One company…
Taysha Gene Therapies Stock: Rett Data Checks Momentum,Road Ahead Rocky (NASDAQ:TSHA)
Investment Overview Taysha Gene Therapies (NASDAQ:TSHA) stock hit the skids yesterday as the Dallas, Texas headquartered biotech reported data from…